Search research articles
Contact Us
Filters
Showing results (271-280 of 359) with videos related to
Page
of 36
Sort By:
Plos One
|
June 7, 2013
Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome
Yukie Yoshii, Takako Furukawa, Nobuyuki Oyama, et al.
Nature Communications
|
May 9, 2022
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
Patrícia M R Pereira, Komal Mandleywala, Sébastien Monette, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 15, 2017
Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
Neeta Pandit-Taskar, Pat Zanzonico, Kevin D Staton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
Shakeel Modak, Pat Zanzonico, Milan Grkovski, et al.
Molecular Pharmaceutics
|
May 31, 2022
Pretargeted PET of Osteodestructive Lesions in Dogs
Charles A Maitz, Samantha Delaney, Brendon E Cook, et al.
Inorganic Chemistry
|
November 10, 2020
Polyazamacrocycle Ligands Facilitate <sup>89</sup>Zr Radiochemistry and Yield <sup>89</sup>Zr Complexes with Remarkable Stability
Darpan N Pandya, Kelly E Henry, Cynthia S Day, et al.
Frontiers in Chemistry
|
August 26, 2022
Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617
José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 7, 2016
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A Ulaner, David M Hyman, Dara S Ross, et al.
Nuclear Medicine and Biology
|
March 6, 2020
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue
Jeroen A C M Goos, Maria Davydova, Thomas R Dilling, et al.
Cancer Research
|
February 23, 2020
iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy
Patricia M R Pereira, Kimberly J Edwards, Komal Mandleywala, et al.
Page
of 36
Search research articles
Search
Showing results (271-280 of 359) with videos related to
Sort By:
Page
of 36
Plos One
|
June 7, 2013
Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome
Yukie Yoshii, Takako Furukawa, Nobuyuki Oyama, et al.
Nature Communications
|
May 9, 2022
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
Patrícia M R Pereira, Komal Mandleywala, Sébastien Monette, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 15, 2017
Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
Neeta Pandit-Taskar, Pat Zanzonico, Kevin D Staton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
Shakeel Modak, Pat Zanzonico, Milan Grkovski, et al.
Molecular Pharmaceutics
|
May 31, 2022
Pretargeted PET of Osteodestructive Lesions in Dogs
Charles A Maitz, Samantha Delaney, Brendon E Cook, et al.
Inorganic Chemistry
|
November 10, 2020
Polyazamacrocycle Ligands Facilitate <sup>89</sup>Zr Radiochemistry and Yield <sup>89</sup>Zr Complexes with Remarkable Stability
Darpan N Pandya, Kelly E Henry, Cynthia S Day, et al.
Frontiers in Chemistry
|
August 26, 2022
Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617
José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 7, 2016
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A Ulaner, David M Hyman, Dara S Ross, et al.
Nuclear Medicine and Biology
|
March 6, 2020
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue
Jeroen A C M Goos, Maria Davydova, Thomas R Dilling, et al.
Cancer Research
|
February 23, 2020
iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy
Patricia M R Pereira, Kimberly J Edwards, Komal Mandleywala, et al.
Page
of 36